Literature DB >> 2827384

Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1.

B Meignier1, R Longnecker, P Mavromara-Nazos, A E Sears, B Roizman.   

Abstract

We report the results of studies on the biologic properties of seven deletion mutants of herpes simplex virus 1 (HSV-1). The genes deleted from six of these mutants map in the S component of HSV-1 DNA and include those specifying the alpha protein 47, the glycoproteins G and E, the viral protein kinase, and two proteins whose functions are not yet known (open reading frames US2 and US11). The seventh virus [HSV-1(F) delta 305] contained a 700-bp deletion in the thymidine kinase gene. The results of intracerebral inoculation of Balb/c mice indicated that all but one of the deletion mutants in the S component were significantly attenuated. The PFU/LD50 ratios for these mutants ranged from 10(4)- to 10(5)-fold higher than that of the wild-type, HSV-1(F). The PFU/LD50 for mutant R7032, from which the glycoprotein E gene had been deleted, was less than 100-fold higher than that of the parent virus. All of the mutants, with one exception, were able to establish latency in mice; the exception, HSV-1(F) delta 305, was able to establish latency in rabbits.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2827384     DOI: 10.1016/0042-6822(88)90417-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  101 in total

1.  Functional anatomy of herpes simplex virus 1 overlapping genes encoding infected-cell protein 22 and US1.5 protein.

Authors:  W O Ogle; B Roizman
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins.

Authors:  J Munger; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

3.  Novel, soluble isoform of the herpes simplex virus (HSV) receptor nectin1 (or PRR1-HIgR-HveC) modulates positively and negatively susceptibility to HSV infection.

Authors:  M Lopez; F Cocchi; E Avitabile; A Leclerc; J Adelaide; G Campadelli-Fiume; P Dubreuil
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  UL34, the target of the herpes simplex virus U(S)3 protein kinase, is a membrane protein which in its unphosphorylated state associates with novel phosphoproteins.

Authors:  F C Purves; D Spector; B Roizman
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

5.  A gammaherpesvirus 68 gene 50 null mutant establishes long-term latency in the lung but fails to vaccinate against a wild-type virus challenge.

Authors:  Janice M Moser; Michael L Farrell; Laurie T Krug; Jason W Upton; Samuel H Speck
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Bcl-2 blocks accretion or depletion of stored calcium but has no effect on the redistribution of IP3 receptor I mediated by glycoprotein E of herpes simplex virus 1.

Authors:  Maria Kalamvoki; Bernard Roizman
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

7.  Genetic and molecular in vivo analysis of herpes simplex virus assembly in murine visual system neurons.

Authors:  Jennifer H LaVail; Andrew N Tauscher; James W Hicks; Ons Harrabi; Gregory T Melroe; David M Knipe
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Regulation of the catalytic activity of herpes simplex virus 1 protein kinase Us3 by autophosphorylation and its role in pathogenesis.

Authors:  Ken Sagou; Takahiko Imai; Hiroshi Sagara; Masashi Uema; Yasushi Kawaguchi
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

9.  Characterization of a nerve growth factor-inducible cellular activity that enhances herpes simplex virus type 1 gene expression and replication of an ICP0 null mutant in cells of neural lineage.

Authors:  R Jordan; J Pepe; P A Schaffer
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Retroviral insertional activation in a herpesvirus: transcriptional activation of US genes by an integrated long terminal repeat in a Marek's disease virus clone.

Authors:  D Jones; P Brunovskis; R Witter; H J Kung
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.